Your browser doesn't support javascript.
loading
A 10-year analysis of metastatic prostate cancer as an initial presentation in an underserved population.
Winer, Andrew G; Sfakianos, John P; Hyacinthe, Llewellyn M; McNeil, Brian K.
Afiliación
  • Winer AG; Department of Urology, SUNY Downstate Medical Center and Kings County Medical Center, Brooklyn, NY, USA.
  • Sfakianos JP; Department of Urology, SUNY Downstate Medical Center and Kings County Medical Center, Brooklyn, NY, USA.
  • Hyacinthe LM; Department of Urology, SUNY Downstate Medical Center and Kings County Medical Center, Brooklyn, NY, USA.
  • McNeil BK; Department of Urology, SUNY Downstate Medical Center and Kings County Medical Center, Brooklyn, NY, USA.
Int Braz J Urol ; 40(3): 316-21, 2014.
Article en En | MEDLINE | ID: mdl-25010297
OBJECTIVE: To analyze patients from an underserved area who presented initially with metastatic prostate cancer in order to identify patients in our population who would suffer greatly if PSA screening was eliminated. MATERIALS AND METHODS: A prospectively maintained androgen deprivation therapy database from an inner city municipal hospital was queried to identify patients who presented with metastatic prostate cancer. We identified 129 individuals from 1999 to 2009 eligible for study. Those who underwent previous treatment for prostate cancer were excluded. We examined metastatic distribution and analyzed survival using Kaplan Meier probability curves. RESULTS: The median age of presentation was 68 with a median Gleason sum of 8 per prostate biopsy. Thirty-two patients presented with hydronephrosis with a median creatinine of 1.79, two of whom required emergent dialysis. Of those patients who underwent radiographic imaging at presentation, 35.5% (33/93) had lymphadenopathy suspicious for metastasis, 16.1% (15/93) had masses suspicious for visceral metastases. Of the patients who underwent a bone scan 93% (118/127) had positive findings with 7.9% (10/127) exhibiting signs of cord compression. The 2 and 5- year cancer specific survival was 92.1% and 65.6%, respectively. CONCLUSIONS: In this study we have highlighted a group of men in an underserved community who presented with aggressive and morbid PCa despite widespread acceptance of PSA screening.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Tamizaje Masivo / Antígeno Prostático Específico / Poblaciones Vulnerables Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Revista: Int Braz J Urol Asunto de la revista: UROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Tamizaje Masivo / Antígeno Prostático Específico / Poblaciones Vulnerables Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Revista: Int Braz J Urol Asunto de la revista: UROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Brasil